Provided by Tiger Trade Technology Pte. Ltd.

Permian Resources Corp

24.26
+0.86003.68%
Post-market: 24.23-0.0300-0.12%19:59 EDT
Volume:10.98M
Turnover:264.17M
Market Cap:20.31B
PE:15.34
High:24.36
Open:23.61
Low:23.49
Close:23.40
52wk High:24.65
52wk Low:11.92
Shares:837.29M
Float Shares:794.89M
Volume Ratio:1.49
T/O Rate:1.38%
Dividend:0.62
Dividend Rate:2.56%
EPS(TTM):1.58
EPS(LYR):1.28
ROE:11.40%
ROA:7.54%
PB:1.69
PE(LYR):18.95

Loading ...

Movement Alert|Permian Resources Rises 5.28% in Regular Trading, Trading at $19.15

Market Focus
·
Jul 08

Permian Resources (PR) Gets a Buy from Wells Fargo

TIPRANKS
·
Jul 04

Permian Resources is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jun 30

Permian Resources price target lowered to $24 from $25 at Morgan Stanley

TIPRANKS
·
Jun 29

How Investors Are Reacting To Permian Resources (PR) Broad Russell Growth Index Inclusion

Simply Wall St.
·
Jun 29

Is Permian Resources (PR) Undervalued As Evercore Starts Coverage Following Its Q1 Earnings Beat?

Simply Wall St.
·
Jun 27

The Lurid Lawsuit, Salami Scandal and Trash-can Thief Vexing Jpmorgan's PR Dept.

Dow Jones
·
Jun 25

Livesense Sets Up Subsidiary to Tackle AI-Driven Technical PR Challenges

MT Newswires Live
·
Jun 24

Livesense to Launch Technical PR Subsidiary to Bolster Engineer Recruitment Services

TIPRANKS
·
Jun 24

Permian Resources Initiated at Outperform by Evercore ISI Group

Dow Jones
·
Jun 23

Permian Resources initiated with an Outperform at Evercore ISI

TIPRANKS
·
Jun 23

Evercore ISI Initiates Permian Resources at Outperform With $25 Price Target

MT Newswires Live
·
Jun 23

Motor finance revs up City watchdog’s PR spend

cityam
·
Jun 22

COP, PR, and FANG Stocks Rise as Roth Capital Upgrades to Buy after Recent Pullback

TIPRANKS
·
Jun 22

Roth Capital Partners Upgrades Permian Resources to Buy From Neutral, Adjusts PT to $23 From $22

MT Newswires Live
·
Jun 22

Permian Resources upgraded to Buy from Neutral at Roth Capital

TIPRANKS
·
Jun 22

Permian Resources Corp : Raymond James Cuts Target Price to $26 From $29

THOMSON REUTERS
·
Jun 17

Private Equity's Push Into 401(k)s Has a Big PR Problem -- Barrons.com

Dow Jones
·
Jun 16

PR TIMES Issues Restricted Shares to Strengthen Equity-Based Remuneration

TIPRANKS
·
Jun 12

C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population

GlobeNewswire
·
Jun 11